DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 6Strides Pharma Science
03 1ACIC Europe API & Pharmaceuticals
04 1Acella Pharmaceuticals
05 13Actavis Inc
06 1Aeon Formulations Private Limited
07 4Ajanta Pharma Limited
08 11Alembic Pharmaceuticals Limited
09 4Amneal Pharmaceuticals
10 1Anwita Drugs & Chemicals Pvt Ltd
11 4Apotex Inc
12 1Aurobindo Pharma Limited
13 6Avet Pharmaceuticals
14 2Bausch & Lomb Incorporated
15 2Caribe Holdings
16 2Changzhou Pharmaceutical Factory
17 9Chartwell Pharmaceuticals llc
18 1DenMat Dental
19 1ENDO OPERATIONS
20 3Epic Pharma. LLC.
21 2Fresenius Kabi USA
22 1GALDERMA LABS LP
23 1GLAND PHARMA LIMITED
24 1Galderma
25 2HALSEY
26 3HEATHER
27 8Hikma Pharmaceuticals
28 1Holden Medical Laboratories Pvt. Ltd
29 2Impax Laboratories
30 3Interpharm
31 2JAMP PHARMA
32 1LABORATOIRE RIVA INC.
33 1LARKEN LABS
34 11Lupin Ltd
35 1MANTRA PHARMA INC
36 2MS Pharma
37 10Mayne Pharma
38 3Mutual Pharmaceutical Company, Inc.
39 1Neopharma
40 2Nesher Pharmaceuticals USA LLC
41 3Nostrum Laboratories
42 1Novel Laboratories, Inc.
43 1ORYZA
44 1PENDOPHARM DIVISION OF DE PHARMASCIENCE INC
45 1PRO DOC LIMITEE
46 2PVT FORM
47 2Par Pharmaceutical
48 4Pelcoat Formulations
49 5Pfizer Inc
50 1Pharmanovia A/S
51 1Pharmaris
52 2Pharmascience Inc.
53 1Pliva Hrvatska
54 1Praxgen
55 3Prinston
56 2Qilu Animal Health Products
57 2Quad Pharma
58 1RACHELLE
59 2RANBAXY LABORATORIES LIMITED
60 1Ratiopharm GmbH
61 7Rising Pharmaceuticals Inc
62 2SANIS HEALTH INC
63 3SUPERPHARM
64 2Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
65 2Slate Run Pharmaceuticals
66 4Sun Pharmaceutical Industries Limited
67 5Teva Pharmaceutical Industries
68 2Torrent Pharmaceuticals Limited
69 2Unichem Laboratories Limited
70 2V-Ensure
71 2Viatris
72 4Warner Chilcott Company, LLC
73 2West-ward Pharmaceutical Corp
74 2Zhejiang Yongtai Technology
75 3Zydus Lifesciences
76 5Zydus Pharmaceuticals
01 9CAPSULE
02 1CAPSULE, COATED PELLETS;ORAL
03 5CAPSULE, DELAYED RELEASE;ORAL
04 53CAPSULE;ORAL
05 1CONCENTRATE FOR SOLUTION FOR INFUSION
06 5Capsule
07 4Enteric Coated Pellets
08 20INJECTABLE;INJECTION
09 1Inection
10 2Injectable; Injection
11 1Injection
12 1ORAL SUSPENSION
13 1Oral Solution/Suspension
14 1Pellet
15 2Powder
16 1SYSTEM, EXTENDED RELEASE;PERIODONTAL
17 9TABLET
18 42TABLET, DELAYED RELEASE;ORAL
19 57TABLET;ORAL
20 2Tablet
21 1WSP / Premix
01 102DISCN
02 6Generic
03 15Prescription
04 77RX
05 19Blank
01 2ACTICLATE
02 1ACTICLATE CAP
03 1APO-DOXY CAP 100MG
04 1APO-DOXY TABS 100MG
05 1ATRIDOX
06 9DORYX
07 2DORYX MPC
08 1DOXIEONnn
09 1DOXY 100
10 1DOXY 200
11 3DOXY-LEMMON
12 1DOXYCHEL HYCLATE
13 1DOXYCIN TAB 100MG
14 7DOXYCYCLINE
15 1DOXYCYCLINE CAPSULES
16 145DOXYCYCLINE HYCLATE
17 1DOXYCYCLINE TABLETS
18 1DOXYTAB
19 1Doxyferm
20 1Doxyline-100
21 1Doxyline-200
22 2Doxy®
23 1JAMP DOXYCYCLINE
24 1JAMP DOXYCYCLINE CAPSULES
25 1LYMEPAK
26 1M-DOXYCYCLINE
27 1Neocycline
28 3PERIOSTAT
29 2PMS-DOXYCYCLINE
30 1PRZ-DOXYCYCLINE
31 2TEVA-DOXYCYCLINE
32 1VIBRA-TABS
33 4VIBRAMYCIN
34 1Vibranord
35 15Blank
01 15Canada
02 4China
03 14India
04 2Jordan
05 2Sweden
06 1U.A.E
07 181USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1986-04-07
Application Number : 62538
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ATRIDOX
Dosage Form : SYSTEM, EXTENDED RELEASE;PERIODONTAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1998-09-03
Application Number : 50751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-09-30
Application Number : 50744
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-02-02
Application Number : 50783
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-07-22
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2001-08-13
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRA-TABS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50533
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?